Lyra Therapeutics, Inc.

Q3 2021 13F Holders

Symbol: LYRA
CUSIP: 55234L105
Type: Equity
Class: COM
Num filings: 38
Total reported value, excl. options: $60.8 M

Compare 2021 Q3 to

Manager	Report Date	Value ($000)	Shares	Option Type